Theratechnologies EBIT Margin 2011-2025 | THTX

Theratechnologies ebit margin from 2011 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues

Theratechnologies EBIT Margin 2011-2025 | THTX

Theratechnologies ebit margin from 2011 to 2025. Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$229.3B
Amgen (AMGN)$159.6B
Gilead Sciences (GILD)$140.8B
Vertex Pharmaceuticals (VRTX)$118.7B
Bristol Myers Squibb (BMY)$90B
CSL (CSLLY)$82.4B
GSK (GSK)$76.6B
Regeneron Pharmaceuticals (REGN)$60.3B
Alnylam Pharmaceuticals (ALNY)$52.7B
Argenex SE (ARGX)$41.2B
BioNTech SE (BNTX)$25.8B
Royalty Pharma (RPRX)$20.9B
Insmed (INSM)$20.6B
Biogen (BIIB)$19.3B
Illumina (ILMN)$15B
Incyte (INCY)$14.8B
Genmab (GNMSF)$14.7B
Genmab (GMAB)$14B
BioMarin Pharmaceutical (BMRN)$11.1B
QIAGEN (QGEN)$11.1B
Moderna (MRNA)$10.7B
Ascendis Pharma (ASND)$10.7B
Swedish Orphan Biovitrum (BIOVF)$10.6B
Exelixis (EXEL)$10B
Exact Sciences (EXAS)$9B
Verona Pharma American Depositary Share (VRNA)$9B
Bio-Techne Corp (TECH)$8.6B
Blueprint Medicines (BPMC)$8.3B
Roivant Sciences (ROIV)$7.7B
Halozyme Therapeutics (HALO)$7.3B